A Prospective Multicenter Study of "Inside Stents" for Biliary Stricture: Multicenter Evolving Inside Stent Registry (MEISteR).
biliary stricture
endoscopic biliary stent placement
inside stent
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
30 Jun 2021
30 Jun 2021
Historique:
received:
08
06
2021
revised:
24
06
2021
accepted:
29
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Endoscopic biliary stent placement is the standard of care for biliary strictures, but stents across the papilla are prone to duodenobiliary reflux, which can cause stent occlusion. Preliminary studies of "inside stents" placed above the papilla showed encouraging outcomes, but prospective data with a large cohort were not reported. This was a prospective multicenter registry of commercially available inside stents for benign and malignant biliary strictures. Primary endpoint was recurrent biliary obstruction (RBO). Secondary endpoints were technical success of stent placement and removal, adverse events, and stricture resolution. A total of 209 inside stents were placed in 132 (51 benign and 81 malignant) cases with biliary strictures in 10 Japanese centers. During the follow-up period of 8.4 months, RBO was observed in 19% of benign strictures. The RBO rate was 49% in malignant strictures, with the median time to RBO of 4.7 months. Technical success rates of stent placement and removal were both 100%. The adverse event rate was 8%. This prospective multicenter study demonstrated that inside stents above the papilla were feasible in malignant and benign biliary strictures, but a randomized controlled trial is warranted to confirm its superiority to conventional stents across the papilla.
Sections du résumé
BACKGROUND
BACKGROUND
Endoscopic biliary stent placement is the standard of care for biliary strictures, but stents across the papilla are prone to duodenobiliary reflux, which can cause stent occlusion. Preliminary studies of "inside stents" placed above the papilla showed encouraging outcomes, but prospective data with a large cohort were not reported.
METHODS
METHODS
This was a prospective multicenter registry of commercially available inside stents for benign and malignant biliary strictures. Primary endpoint was recurrent biliary obstruction (RBO). Secondary endpoints were technical success of stent placement and removal, adverse events, and stricture resolution.
RESULTS
RESULTS
A total of 209 inside stents were placed in 132 (51 benign and 81 malignant) cases with biliary strictures in 10 Japanese centers. During the follow-up period of 8.4 months, RBO was observed in 19% of benign strictures. The RBO rate was 49% in malignant strictures, with the median time to RBO of 4.7 months. Technical success rates of stent placement and removal were both 100%. The adverse event rate was 8%.
CONCLUSION
CONCLUSIONS
This prospective multicenter study demonstrated that inside stents above the papilla were feasible in malignant and benign biliary strictures, but a randomized controlled trial is warranted to confirm its superiority to conventional stents across the papilla.
Identifiants
pubmed: 34208969
pii: jcm10132936
doi: 10.3390/jcm10132936
pmc: PMC8268973
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Intern Med. 1988 Apr;108(4):546-53
pubmed: 2450501
Endoscopy. 2019 Sep;51(9):843-851
pubmed: 30414164
Gastrointest Endosc. 2019 Aug;90(2):222-230
pubmed: 30905729
J Hepatobiliary Pancreat Sci. 2013 Feb;20(2):214-22
pubmed: 22415652
BMC Gastroenterol. 2013 Feb 14;13:31
pubmed: 23410217
Transplantation. 2003 Sep 15;76(5):810-5
pubmed: 14501859
Dig Endosc. 2021 Mar;33(3):451-457
pubmed: 32559351
Endoscopy. 2020 May;52(5):368-376
pubmed: 32092770
J Hepatobiliary Pancreat Sci. 2014 May;21(5):349-55
pubmed: 24123806
Endoscopy. 2005 Aug;37(8):729-34
pubmed: 16032491
Endoscopy. 1980 Jan;12(1):8-11
pubmed: 7353562
Gastrointest Endosc. 2010 Mar;71(3):446-54
pubmed: 20189503
Liver Int. 2019 Oct;39(10):1954-1963
pubmed: 31436017
Gastrointest Endosc. 2012 May;75(5):1080-5
pubmed: 22401821
J Gastroenterol. 2013 Sep;48(9):1097-104
pubmed: 23325164
J Gastroenterol Hepatol. 1992 May-Jun;7(3):240-5
pubmed: 1611012
Surg Today. 2021 Apr 9;:
pubmed: 33835263
Dig Endosc. 2019 Sep;31(5):566-574
pubmed: 30803046
Lancet. 1994 Aug 27;344(8922):581-2
pubmed: 7914962
Dig Endosc. 2013 May;25 Suppl 2:94-9
pubmed: 23617658
Dig Endosc. 2014 Jan;26(1):93-9
pubmed: 23517109
Dig Dis Sci. 2020 Dec;65(12):3710-3718
pubmed: 32107675
Endoscopy. 1998 Oct;30(8):687-90
pubmed: 9865557
Dig Endosc. 2021 Mar;33(3):310-320
pubmed: 32250476
Dig Endosc. 2021 May 4;:
pubmed: 33949009
Dig Endosc. 2021 Jul;33(5):840-848
pubmed: 33043522
J Hepatobiliary Pancreat Sci. 2021 Jan;28(1):26-54
pubmed: 33259690
Am J Gastroenterol. 1999 Nov;94(11):3197-201
pubmed: 10566714
Gastrointest Endosc. 2017 Nov;86(5):817-827
pubmed: 28479493
Dig Endosc. 2020 Jan;32(2):275-286
pubmed: 31578770
J Gastroenterol. 2011 Feb;46(2):242-8
pubmed: 20700608
BMC Gastroenterol. 2015 Feb 05;15:8
pubmed: 25649526
Lancet. 1992 Dec 19-26;340(8834-8835):1488-92
pubmed: 1281903
Am J Gastroenterol. 2006 Oct;101(10):2230-6
pubmed: 16952286
Dig Endosc. 2015 Jan;27(2):259-64
pubmed: 25209944